367 related articles for article (PubMed ID: 23279949)
1. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
[TBL] [Abstract][Full Text] [Related]
2. Duration of viral shedding and factors associated with prolonged shedding among inpatients with influenza treated with oseltamivir: a prospective cohort study.
Khoury J; Szwarcwort M; Kra-Oz Z; Saffuri M; Seh K; Yahalomi T; Braun E; Azzam ZS; Paul M; Neuberger A
Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):319-323. PubMed ID: 29143145
[TBL] [Abstract][Full Text] [Related]
3. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
Yu H; Liao Q; Yuan Y; Zhou L; Xiang N; Huai Y; Guo X; Zheng Y; van Doorn HR; Farrar J; Gao Z; Feng Z; Wang Y; Yang W
BMJ; 2010 Sep; 341():c4779. PubMed ID: 20876641
[TBL] [Abstract][Full Text] [Related]
5. Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.
Wang YG; Jiang M; Wang RB; Zha QL; Zhang SJ; Zhou GQ; Li XW; Wang YY; Lv AP
J Tradit Chin Med; 2012 Jun; 32(2):148-55. PubMed ID: 22876436
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
7. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection.
Na S; Chong YP; Kim MN; Kim WY; Kim W; Hong SB; Lim CM; Koh Y; Kwon JW; Hong SJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Med Virol; 2011 Jan; 83(1):5-9. PubMed ID: 21108333
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
[TBL] [Abstract][Full Text] [Related]
9. Viral shedding and susceptibility to oseltamivir in hospitalized immunocompromised patients with influenza in the Influenza Resistance Information Study (IRIS).
Fraaij PL; Schutten M; Javouhey E; Burleigh L; Outlaw R; Kumar D; Boucher CA
Antivir Ther; 2015; 20(6):633-42. PubMed ID: 25849228
[TBL] [Abstract][Full Text] [Related]
10. H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis.
Souza TM; Salluh JI; Bozza FA; Mesquita M; Soares M; Motta FC; Pitrowsky MT; de Lourdes Oliveira M; Mishin VP; Gubareva LV; Whitney A; Rocco SA; Gonçalves VM; Marques VP; Velasco E; Siqueira MM
PLoS One; 2010 Nov; 5(11):e14158. PubMed ID: 21152402
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for prolonged shedding of 2009 H1N1 influenza virus.
Chen Y; Qiao H; Zhang CM; Tong M; Shang S
Indian Pediatr; 2011 Dec; 48(12):961-3. PubMed ID: 21719940
[TBL] [Abstract][Full Text] [Related]
12. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
[TBL] [Abstract][Full Text] [Related]
13. Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010.
Malato L; Llavador V; Marmier E; Youssef J; Balick Weber C; Rozé H; Bessede E; Fleury HJ
Euro Surveill; 2011 Jan; 16(4):. PubMed ID: 21284922
[TBL] [Abstract][Full Text] [Related]
14. Duration of viral shedding in hospitalized patients infected with pandemic H1N1.
Meschi S; Selleri M; Lalle E; Bordi L; Valli MB; Ferraro F; Ippolito G; Petrosillo N; Lauria FN; Capobianchi MR
BMC Infect Dis; 2011 May; 11():140. PubMed ID: 21605362
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy.
Charlier C; Enouf V; Lanternier F; Grandadam M; Amazzough K; Blanche S; Lecuit M; Lortholary O; van der Werf S
Clin Microbiol Infect; 2009 Dec; 15(12):1189-91. PubMed ID: 19681951
[TBL] [Abstract][Full Text] [Related]
16. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.
Leung YH; Lim WL; Wong MH; Chuang SK
Epidemiol Infect; 2012 May; 140(5):814-7. PubMed ID: 21801465
[TBL] [Abstract][Full Text] [Related]
17. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
[TBL] [Abstract][Full Text] [Related]
18. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
[TBL] [Abstract][Full Text] [Related]
19. Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment.
Gandhoke I; Rawat DS; Rai A; Khare S; Ichhpujani RL
Indian J Med Microbiol; 2011; 29(1):37-41. PubMed ID: 21304193
[TBL] [Abstract][Full Text] [Related]
20. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
